186 related articles for article (PubMed ID: 37334365)
1. SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics.
Lim Kam Sian TCC; Goncalves G; Steele JR; Shamekhi T; Bramberger L; Jin D; Shahbazy M; Purcell AW; Ramarathinam S; Stoychev S; Faridi P
Front Immunol; 2023; 14():1107576. PubMed ID: 37334365
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
[TBL] [Abstract][Full Text] [Related]
3. Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry.
Phulphagar KM; Ctortecka C; Jacome ASV; Klaeger S; Verzani EK; Hernandez GM; Udeshi ND; Clauser KR; Abelin JG; Carr SA
Mol Cell Proteomics; 2023 Jun; 22(6):100563. PubMed ID: 37142057
[TBL] [Abstract][Full Text] [Related]
4. Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.
ElAbd H; Franke A
Methods Mol Biol; 2024; 2758():425-443. PubMed ID: 38549028
[TBL] [Abstract][Full Text] [Related]
5. Sensitive Immunopeptidomics by Leveraging Available Large-Scale Multi-HLA Spectral Libraries, Data-Independent Acquisition, and MS/MS Prediction.
Pak H; Michaux J; Huber F; Chong C; Stevenson BJ; Müller M; Coukos G; Bassani-Sternberg M
Mol Cell Proteomics; 2021; 20():100080. PubMed ID: 33845167
[TBL] [Abstract][Full Text] [Related]
6. The impact of immunopeptidomics: From basic research to clinical implementation.
Shapiro IE; Bassani-Sternberg M
Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
[TBL] [Abstract][Full Text] [Related]
7. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
Front Immunol; 2018; 9():912. PubMed ID: 29780384
[TBL] [Abstract][Full Text] [Related]
8. IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma.
Wahle M; Thielert M; Zwiebel M; Skowronek P; Zeng WF; Mann M
Mol Cell Proteomics; 2024 Jan; 23(1):100689. PubMed ID: 38043703
[TBL] [Abstract][Full Text] [Related]
9. TOF
Hoenisch Gravel N; Nelde A; Bauer J; Mühlenbruch L; Schroeder SM; Neidert MC; Scheid J; Lemke S; Dubbelaar ML; Wacker M; Dengler A; Klein R; Mauz PS; Löwenheim H; Hauri-Hohl M; Martin R; Hennenlotter J; Stenzl A; Heitmann JS; Salih HR; Rammensee HG; Walz JS
Nat Commun; 2023 Nov; 14(1):7472. PubMed ID: 37978195
[TBL] [Abstract][Full Text] [Related]
10. The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.
Vizcaíno JA; Kubiniok P; Kovalchik KA; Ma Q; Duquette JD; Mongrain I; Deutsch EW; Peters B; Sette A; Sirois I; Caron E
Mol Cell Proteomics; 2020 Jan; 19(1):31-49. PubMed ID: 31744855
[TBL] [Abstract][Full Text] [Related]
11. Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation.
Jin D; Loh KL; Shamekhi T; Ting YT; Lim Kam Sian TCC; Roest J; Ooi JD; Vivian JP; Faridi P
Methods Mol Biol; 2023; 2691():351-369. PubMed ID: 37355557
[TBL] [Abstract][Full Text] [Related]
12. Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
Sirois I; Isabelle M; Duquette JD; Saab F; Caron E
J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723952
[TBL] [Abstract][Full Text] [Related]
13. Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins.
ElAbd H; Bacher P; Tholey A; Lenz TL; Franke A
Front Immunol; 2023; 14():1107266. PubMed ID: 37063883
[TBL] [Abstract][Full Text] [Related]
14. MHCpLogics: an interactive machine learning-based tool for unsupervised data visualization and cluster analysis of immunopeptidomes.
Shahbazy M; Ramarathinam SH; Li C; Illing PT; Faridi P; Croft NP; Purcell AW
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38487848
[TBL] [Abstract][Full Text] [Related]
15. Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform.
Ritz D; Kinzi J; Neri D; Fugmann T
Proteomics; 2017 Oct; 17(19):. PubMed ID: 28834231
[TBL] [Abstract][Full Text] [Related]
16. Generation of HLA Allele-Specific Spectral Libraries to Identify and Quantify Immunopeptidomes by SWATH/DIA-MS.
Kovalchik K; Hamelin D; Caron E
Methods Mol Biol; 2022; 2420():137-147. PubMed ID: 34905171
[TBL] [Abstract][Full Text] [Related]
17. In Immunopeptidomics We Need a Sniper Instead of a Shotgun.
Faridi P; Purcell AW; Croft NP
Proteomics; 2018 Jun; 18(12):e1700464. PubMed ID: 29377634
[TBL] [Abstract][Full Text] [Related]
18. Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry.
Phulphagar KM; Ctortecka C; Vaca Jacome AS; Klaeger S; Verzani EK; Hernandez GM; Udeshi N; Clauser K; Abelin J; Carr SA
bioRxiv; 2023 Mar; ():. PubMed ID: 36993564
[TBL] [Abstract][Full Text] [Related]
19. Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data.
ElAbd H; Degenhardt F; Koudelka T; Kamps AK; Tholey A; Bacher P; Lenz TL; Franke A; Wendorff M
BMC Bioinformatics; 2021 Aug; 22(1):405. PubMed ID: 34404349
[TBL] [Abstract][Full Text] [Related]
20. Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery.
Zhang B; Bassani-Sternberg M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
